ATE335074T1 - Verwendung eines klones von infektiösen und attenuierten typ ii rinderdiarrhöviren um fötal infektion von typ i bvdv zu vermeiden - Google Patents
Verwendung eines klones von infektiösen und attenuierten typ ii rinderdiarrhöviren um fötal infektion von typ i bvdv zu vermeidenInfo
- Publication number
- ATE335074T1 ATE335074T1 AT02797952T AT02797952T ATE335074T1 AT E335074 T1 ATE335074 T1 AT E335074T1 AT 02797952 T AT02797952 T AT 02797952T AT 02797952 T AT02797952 T AT 02797952T AT E335074 T1 ATE335074 T1 AT E335074T1
- Authority
- AT
- Austria
- Prior art keywords
- type
- diarrhovirus
- bvdv
- clone
- infectious
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title 2
- 241000283690 Bos taurus Species 0.000 title 1
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 title 1
- PPBOKXIGFIBOGK-BDTUAEFFSA-N bvdv Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C1=CN=CN1 PPBOKXIGFIBOGK-BDTUAEFFSA-N 0.000 title 1
- 230000001605 fetal effect Effects 0.000 title 1
- 230000002458 infectious effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10143813A DE10143813A1 (de) | 2001-09-06 | 2001-09-06 | Infektiöser Rindervirusdiarrhoe-Virusklon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE335074T1 true ATE335074T1 (de) | 2006-08-15 |
Family
ID=7697990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02797952T ATE335074T1 (de) | 2001-09-06 | 2002-09-05 | Verwendung eines klones von infektiösen und attenuierten typ ii rinderdiarrhöviren um fötal infektion von typ i bvdv zu vermeiden |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP1749885B8 (enExample) |
| JP (2) | JP4416504B2 (enExample) |
| KR (1) | KR20040039295A (enExample) |
| CN (1) | CN1551913A (enExample) |
| AR (1) | AR036432A1 (enExample) |
| AT (1) | ATE335074T1 (enExample) |
| BR (1) | BR0212312A (enExample) |
| CA (1) | CA2457441C (enExample) |
| DE (2) | DE10143813A1 (enExample) |
| DK (1) | DK1749885T3 (enExample) |
| ES (1) | ES2401072T3 (enExample) |
| HU (1) | HUP0401585A3 (enExample) |
| MX (1) | MXPA04002124A (enExample) |
| PL (1) | PL368748A1 (enExample) |
| UY (1) | UY27434A1 (enExample) |
| WO (1) | WO2003023041A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
| EP2039773B1 (en) | 2003-03-27 | 2011-12-28 | Ottawa Hospital Research Institute | Mutant vesicular stomatitis viruses and use thereof |
| DE102004025452A1 (de) * | 2004-05-19 | 2006-01-19 | Boehringer Ingelheim Vetmedica Gmbh | Vakzine enthaltend BVDV |
| US7572455B2 (en) | 2004-05-19 | 2009-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine comprising an attenuated pestivirus |
| US20090068223A1 (en) * | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| UY31930A (es) | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
| KR200451870Y1 (ko) * | 2008-07-08 | 2011-01-14 | 박윤규 | 일회용 액상 내용물 용기 |
| KR101453146B1 (ko) * | 2008-12-03 | 2014-10-27 | 조에티스 엘엘씨 | 변형된 ｅｒｎｓ 단백질을 갖는 소 바이러스성 설사증 바이러스 |
| US8846054B2 (en) | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
| CN101906487A (zh) * | 2010-08-05 | 2010-12-08 | 中国兽医药品监察所 | 一种猪瘟病毒核酸标准物质的制备方法 |
| MX347911B (es) | 2010-09-21 | 2017-05-17 | Intervet Int Bv | Vacuna contra virus de diarrea viral de bovinos. |
| WO2014201259A1 (en) * | 2013-06-12 | 2014-12-18 | The Board Of Regents For Oklahoma State University | Fluttering ear tag for bovine vaccination |
| CN113230394B (zh) * | 2021-04-30 | 2024-04-30 | 广州源博医药科技有限公司 | 一种用于牛病毒性腹泻的rna疫苗及其构建方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1104676A1 (en) * | 1999-11-30 | 2001-06-06 | Boehringer Ingelheim Vetmedica Gmbh | Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
-
2001
- 2001-09-06 DE DE10143813A patent/DE10143813A1/de not_active Withdrawn
-
2002
- 2002-09-05 AT AT02797952T patent/ATE335074T1/de not_active IP Right Cessation
- 2002-09-05 HU HU0401585A patent/HUP0401585A3/hu unknown
- 2002-09-05 EP EP06011790A patent/EP1749885B8/en not_active Expired - Lifetime
- 2002-09-05 KR KR10-2004-7002362A patent/KR20040039295A/ko not_active Withdrawn
- 2002-09-05 ES ES06011790T patent/ES2401072T3/es not_active Expired - Lifetime
- 2002-09-05 CA CA2457441A patent/CA2457441C/en not_active Expired - Lifetime
- 2002-09-05 CN CNA028175115A patent/CN1551913A/zh active Pending
- 2002-09-05 WO PCT/EP2002/009925 patent/WO2003023041A2/en not_active Ceased
- 2002-09-05 DK DK06011790.0T patent/DK1749885T3/da active
- 2002-09-05 UY UY27434A patent/UY27434A1/es not_active Application Discontinuation
- 2002-09-05 MX MXPA04002124A patent/MXPA04002124A/es active IP Right Grant
- 2002-09-05 BR BR0212312-6A patent/BR0212312A/pt not_active IP Right Cessation
- 2002-09-05 DE DE60213639T patent/DE60213639T2/de not_active Expired - Lifetime
- 2002-09-05 JP JP2003527105A patent/JP4416504B2/ja not_active Expired - Lifetime
- 2002-09-05 EP EP02797952A patent/EP1440149B1/en not_active Expired - Lifetime
- 2002-09-05 PL PL02368748A patent/PL368748A1/xx not_active Application Discontinuation
- 2002-09-06 AR ARP020103361A patent/AR036432A1/es unknown
-
2009
- 2009-08-03 JP JP2009180719A patent/JP2009291203A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009291203A (ja) | 2009-12-17 |
| ES2401072T3 (es) | 2013-04-16 |
| AR036432A1 (es) | 2004-09-08 |
| CA2457441A1 (en) | 2003-03-20 |
| EP1440149A2 (en) | 2004-07-28 |
| DK1749885T3 (da) | 2013-03-11 |
| EP1749885A2 (en) | 2007-02-07 |
| DE10143813A1 (de) | 2003-04-10 |
| DE60213639T2 (de) | 2007-10-18 |
| EP1440149B1 (en) | 2006-08-02 |
| HUP0401585A2 (hu) | 2004-11-29 |
| EP1749885A3 (en) | 2007-08-29 |
| EP1749885B1 (en) | 2012-12-05 |
| BR0212312A (pt) | 2004-10-13 |
| UY27434A1 (es) | 2003-04-30 |
| CA2457441C (en) | 2013-01-08 |
| KR20040039295A (ko) | 2004-05-10 |
| WO2003023041A2 (en) | 2003-03-20 |
| PL368748A1 (en) | 2005-04-04 |
| DE60213639D1 (de) | 2006-09-14 |
| JP4416504B2 (ja) | 2010-02-17 |
| HUP0401585A3 (en) | 2005-02-28 |
| MXPA04002124A (es) | 2004-07-08 |
| CN1551913A (zh) | 2004-12-01 |
| EP1749885B8 (en) | 2013-01-16 |
| WO2003023041A3 (en) | 2003-11-20 |
| JP2005502361A (ja) | 2005-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE335074T1 (de) | Verwendung eines klones von infektiösen und attenuierten typ ii rinderdiarrhöviren um fötal infektion von typ i bvdv zu vermeiden | |
| DE60234602D1 (de) | Ng eines anbringungsteils an einer hauptkörpereinrichtung, anbringungsteil und batteriepack dafür | |
| DE60215919D1 (de) | 4-fluoro-n-indan-2-yl benzamid und seine verwendung als arzneimittel | |
| ATE471148T1 (de) | Medizinische verwendung eines tetrahydrotriazoloä4,3-aüpyrazins | |
| DE60209182D1 (de) | Erzeugung von Rufdetailaufzeichnungen | |
| DE60223747D1 (de) | Am Handgelenk zu tragende Manschette eines Blutdruckmessgeräts | |
| NO20035485L (no) | Tiofenderivater som antivirale midler for flavivirusinfeksjon | |
| JP2002517569A5 (enExample) | ||
| DE50111949D1 (de) | Komponente einer Strömungsmaschine | |
| DE60122718D1 (de) | Strukturen und zusammensetzungen zur erhöhung der stabilität von aktiven peroxiden | |
| GEP20104960B (en) | USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN | |
| DE60227980D1 (de) | Methode und einrichtung, um den ölverbrauch einer gasturbine zu minimalisieren | |
| DE60223841D1 (de) | Medizinische verwendung von gsk3-hemmenden oxindolderivaten | |
| ATE327765T1 (de) | Methoden um rotavirusvarianten zu trennen und lebender attenuierter rotavirus impfstoff | |
| EP1466979A4 (en) | LYSYL OXIDASES MUSHROOM ORIGIN | |
| DE60225014D1 (de) | Pharmazeutische zusammensetzungen von amlodipin und atorvastatin | |
| DE60132961D1 (de) | Unabhängige Initialisierung von Arbitern und Agenten, um verzögerte Agent-Initialisierung zu ermöglichen | |
| DE60228093D1 (de) | Filtervorrichtung vom externen typ | |
| DE60232552D1 (de) | Invertiertes verzeichnis um zugang zu einer niedrigen cachestufe zu erleichtern | |
| ITMI20010737A0 (it) | Adesivo per protesi dentarie e procedimenti per la sua preparazione | |
| FR2826207B1 (fr) | Convertisseur analogique-numerique sigma-delta passe-bande et convertisseur sigma-delta mash l'incorporant | |
| PL377557A1 (pl) | Zastosowanie rezweratrolu do otrzymywania leku użytecznego w leczeniu infekcji wywołanej wirusem grypy | |
| EP1361850A4 (en) | Use of (gamma-hydroxy-n-methyl-l-leucine9) cyclosporin a for hair growth | |
| EP1469888A4 (en) | STEM CELL SCREENING AND TRANSPLANTATION THERAPY IN HIV INFECTION | |
| DE60040380D1 (de) | Gesicherte Typ D Master-Slave Kippschaltung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |